| Literature DB >> 34151142 |
Peter Kechker1, Yigal Senderovich1, Shifra Ken-Dror1, Sivan Laviad-Shitrit2, Malka Halpern2,3.
Abstract
Tsukamurella pulmonis ( Actinobacteria ), a Gram-positive, obligate aerobic and weakly or variably acid-fast bacterium, is an opportunistic pathogen. Here we report two cases of conjunctivitis caused by T. pulmonis . Both patients had a previous history of nasolacrimal duct obstruction (NLDO). Isolation of T. pulmonis was performed on chocolate, tryptic soy blood and Columbia nalidixic agars. After 24 h of incubation, odourless, white-greyish, membrane-like colonies were observed. The VITEK-2 bacterial identifier system failed to identify the species, while Vitek-MS matrix-assisted laser desorption ionization time-of-flight technology, successfully identified the isolate from case 2 but not from case 1. Final identification was verified using 16S rRNA gene sequencing. An antibiogram was performed and according to the results cefazoline in addition to vancomycin eye drops for 5 days, were suggested as a treatment in case 1. In case 2 the infection was ended without treatment. This is the first report of Tsukamurella as a pathogen that causes conjunctivitis in patients with NLDO.Entities:
Keywords: Tsukamurella pulmonis; acid-fast; conjunctivitis; eye infection; nasolacrimal duct obstruction; opportunistic pathogen
Year: 2020 PMID: 34151142 PMCID: PMC8209640 DOI: 10.1099/acmi.0.000185
Source DB: PubMed Journal: Access Microbiol ISSN: 2516-8290
Fig. 1.Colonial appearance of on a Columbia nalidixic agar plate (a) 24 h and (b) 6 days after inoculation.
Fig. 2.Phylogenetic tree showing the relationship of the isolates from case 1 and case 2 with other species. Sequence alignment was performed using the clustal w program, and the tree was generated using the neighbour-joining method with Kimura two-parameter distances in mega 4.1 software. Bootstrap values (from 1000 replicates) greater than 50 % are shown at branch points. Bar, 0.2 % sequence divergence.
MICs (µg ml–1) of strains
|
Antibiotic |
Case 1 |
Case 2 |
|---|---|---|
|
Ceftriaxone |
2.0 |
12.0 |
|
Meropenem |
2.0 |
0.38 |
|
Gentamycin |
12.0 |
4.0 |
|
Ciprofloxacin |
0.38 |
0.38 |
|
Tetracycline |
0.5 |
12.0 |
|
Clarithromycin |
0.75 |
2.0 |
|
Vancomycin |
4.0 |
4.0 |
conjunctivitis infection in humans
|
Age (years) |
Sex |
Background |
Antibiotic eye drop |
Oral antibiotics |
Duration of treatment |
Outcome |
Reference |
|---|---|---|---|---|---|---|---|
|
>70 |
M |
Nasolacrimal duct obstruction (NLDO), diabetes mellitus with diabetic nephropathy, chronic heart failure and ischaemic heart disease |
Cefazoline and vancomycin |
None |
1 week |
Resolved |
Current study |
|
0.5 |
M |
NLDO |
Dexamethasone–neomycin–polymyxin (given before species identification) |
None |
1 week |
Resolved |
Current study |
|
50 |
F |
Ocular implant infection after enucleation |
Fusidic acid and gentamicin |
Clarithromycin; doxycycline |
22 weeks |
Ocular implant removal |
[ |
|
75 |
M |
Ocular cicatricial pemphigoid; bullous pemphigoid; hypertension |
Chloramphenicol and fusidic acid |
Doxycycline |
2 weeks |
Resolved |
[ |
|
44 |
F |
– |
Chloramphenicol |
None |
1 week |
Resolved |
[ |
|
50 |
F |
Blepharoconjunctivitis, non-insulin-dependent diabetes mellitus, hypertension and systemic lupus erythematosus |
Gentamicin |
None |
2 weeks |
Resolved |
[ |
|
81 |
F |
Posterior blepharitis, hypertension, non-insulin-dependent diabetes mellitus and successful cataract extraction in the right eye |
Tobramycin and dexamethasone (Tobradex) |
None |
2 weeks |
Resolved |
[ |
|
69 |
F |
Hypertension and bronchogenic carcinoma with right upper lobectomy |
Polymyxin B–neomycin |
None |
10 days |
Resolved |
[ |